Tumor thickness as an independent risk factor of early recurrence in oral cavity squamous cell carcinoma

Carregando...
Imagem de Miniatura
Citações na Scopus
30
Tipo de produção
article
Data de publicação
2014
Editora
SPRINGER
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, v.271, n.6, p.1747-1754, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The aim is to determine if tumor thickness is a risk factor related to the development of early recurrences in surgically treated oral cavity squamous cell carcinoma (SCC). Retrospective cohort study conducted at Instituto do CA cent ncer do Estado de So Paulo (ICESP). Fifty-seven patients with oral cavity SCC (excluding lip tumors and patients previously submitted to any treatment) were analyzed regarding the occurrence of an early disease progression (locoregional or distant metastasis) within the first 12 months after initial treatment. Tumor thickness and other histological characteristics related to the development of recurrence up to 1 year after treatment were tested. Results demonstrated that tumor thickness greater than 10 mm (P = 0.034), as well as angiolymphatic invasion (P = 0.001), perineural invasion (P = 0.041) and lymph-node metastasis (P = 0.021) was associated with a worse 12-month disease-free survival (Log-Rank test). In multivariate analysis, tumor thickness greater than 10 mm emerged as an independent risk factor for early recurrence in oral cavity tumors (HR = 3.4, 95 % CI: 1.005-11.690; P = 0.049-Cox regression). Post-operative radiotherapy seems to be a protective factor for early recurrences in patients with tumor thickness greater than 10 mm (P = 0.017-Log-Rank test; HR = 0.32, 95 % CI: 0.12-0.87, P = 0.026-Cox regression). The results of the present research suggest that tumor thickness greater than 10 mm may be an independent adverse factor for early progression of surgically treated oral cavity SCC. Adjuvant therapies, in particular post-operative radiotherapy, should be advocated in this group of patients, regardless of the co-existence of other well-described histological risk factors.
Palavras-chave
Squamous cell carcinoma, Oral cavity neoplasms, Tumor thickness, Prognosis
Referências
  1. Agra IMG, 2006, HEAD NECK-J SCI SPEC, V28, P107, DOI 10.1002/hed.20309
  2. Bonnardot L, 2011, HEAD NECK-J SCI SPEC, V33, P928, DOI 10.1002/hed.21567
  3. BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017
  4. BRESLOW A, 1975, ANN SURG, V182, P572, DOI 10.1097/00000658-197511000-00007
  5. Chuang HC, 2011, HEAD NECK-J SCI SPEC, V33, P1703, DOI 10.1002/hed.21662
  6. Fagan JJ, 1998, ARCH OTOLARYNGOL, V124, P637
  7. Fukano H, 1997, HEAD NECK-J SCI SPEC, V19, P205, DOI 10.1002/(SICI)1097-0347(199705)19:3<205::AID-HED7>3.0.CO;2-6
  8. Gonzalez-Garcia R, 2009, HEAD NECK-J SCI SPEC, V31, P1168, DOI 10.1002/hed.21088
  9. Greenberg JS, 2003, CANCER, V97, P1464, DOI 10.1002/cncr.11202
  10. Hicks WL, 1998, AM J OTOLARYNG, V19, P24, DOI 10.1016/S0196-0709(98)90061-8
  11. Huang SH, 2009, CANCER, V115, P1489, DOI 10.1002/cncr.24161
  12. Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]
  13. Jones HB, 2009, ORAL ONCOL, V45, P10, DOI 10.1016/j.oraloncology.2008.03.009
  14. Keski-Santti H, 2006, ORAL ONCOL, V42, P96, DOI 10.1016/j.oraloncology.2005.06.018
  15. Liao CT, 2008, ANN SURG ONCOL, V15, P915, DOI 10.1245/s10434-007-9761-5
  16. Liu SA, 2007, OTOLARYNG HEAD NECK, V136, P112, DOI 10.1016/j.otohns.2006.07.002
  17. Lodder WL, 2011, EUR RADIOL, V21, P98, DOI 10.1007/s00330-010-1891-7
  18. Lwin CT, 2012, ORAL ONCOL, V48, P149, DOI 10.1016/j.oraloncology.2011.11.002
  19. Menezes MB, 2007, ORAL ONCOL, V43, P656, DOI 10.1016/j.oraloncology.2006.08.004
  20. MOHITTABATABAI MA, 1986, AM J SURG, V152, P351, DOI 10.1016/0002-9610(86)90303-X
  21. MOORE C, 1986, ARCH SURG-CHICAGO, V121, P1410
  22. Mucke T, 2009, ORAL ONCOL, V45, P687, DOI 10.1016/j.oraloncology.2008.10.011
  23. O-charoenrat P, 2003, ORAL ONCOL, V39, P386, DOI 10.1016/S1368-8375(02)00142-2
  24. Patel RS, 2009, ANZ J SURG, V79, P19, DOI 10.1111/j.1445-2197.2008.04791.x
  25. Pentenero M, 2005, HEAD NECK-J SCI SPEC, V27, P1080, DOI 10.1002/hed.20275
  26. PINTO FR, 2012, REV BRAS CIR CABECA, V41, P53
  27. Ross GL, 2004, ANN SURG ONCOL, V11, P213, DOI 10.1245/ASO.2004.03.057
  28. Sessions DG, 2002, LARYNGOSCOPE, V112, P616, DOI 10.1097/00005537-200204000-00005
  29. SPIRO RH, 1986, AM J SURG, V152, P345, DOI 10.1016/0002-9610(86)90302-8
  30. TEICHGRAEBER JF, 1984, HEAD NECK SURG, V7, P15, DOI 10.1002/hed.2890070105
  31. Vanni CMRS, 2010, EUR ARCH OTO-RHINO-L, V267, P1141, DOI 10.1007/s00405-010-1203-5
  32. Yuen APW, 1999, AM J SURG, V177, P90, DOI 10.1016/S0002-9610(98)00294-3